FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/077464 [Registered on: 28/11/2024] Trial Registered Prospectively
Last Modified On: 05/06/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Dentistry 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Bone graft with or without growth factor in bone defects 
Scientific Title of Study   Comparative Evaluation of Efficacy of Demineralized Freeze Dried Bone Allograft (DFDBA)With or Without Recombinant Human Bone Morphogenetic Protein (Rh-BMP2) in the Treatment of Human Intrabony Periodontal Defects. A Clinico-Radiographic Study  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ginni Verma 
Designation  Junior Resident 
Affiliation  Subharti Dental College and Hospital 
Address  Department of Periodontology Subharti Dental College and Hospital Meerut

Meerut
UTTAR PRADESH
250005
India 
Phone  8448214954  
Fax    
Email  ginniverma662@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shivi Khattri 
Designation  Associate Professor 
Affiliation  Subharti Dental College and Hospital 
Address  Department of Periodontology Subharti Dental College and Hospital Meerut

Meerut
UTTAR PRADESH
250005
India 
Phone  9627600088  
Fax    
Email  shivikhattri123@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Ginni Verma 
Designation  Junior Resident 
Affiliation  Subharti Dental College and Hospital 
Address  Department of Periodontology Subharti Dental College and Hospital Meerut


UTTAR PRADESH
250005
India 
Phone  8448214954  
Fax    
Email  ginniverma662@gmail.com  
 
Source of Monetary or Material Support  
Subharti Dental College & Hospital Swami Vivekanand Subharti University Meerut 250005 Uttar Pradesh India 
 
Primary Sponsor  
Name  Ginni Verma 
Address  Department of Periodontology Subharti Dental College and Hospital NH 58 Delhi Haridwar Bypass Road Meerut 250005 Meerut Uttar Pradesh India 
Type of Sponsor  Other [Self ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ginni Verma  Subharti Dental College and Hospital  Room No 2 Department of Periodontology and Implantology Ground floor Subharti dental college and hospital Swami Vivekanand Subharti University, NH-58, Delhi Haridwar Bypass Road, Meerut
Meerut
UTTAR PRADESH 
8448214954

ginniverma662@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
University Ethics Committee,Swami Vivekanand Subharti University  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K053||Chronic periodontitis, (2) ICD-10 Condition: K03||Other diseases of hard tissues ofteeth, (3) ICD-10 Condition: Z789||Other specified health status,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Bone graft only  Open flap debridement with DFDBA. Frequency-Patient recall after 1 week,3 months and 6 months Total duration-6 months for follow up 
Intervention  rhBMP2 group  Open flap debridement with rhBMP-2 with or without DFDBA. Frequency-Patient recall after 1 week, 3 months and 6 months Total duration- 6 months for follow up 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  55.00 Year(s)
Gender  Both 
Details  1) Age group ranging from 20-55 years.
2) Patients having minimum 20 teeth.
3) Clinical attachment loss ≥ 3mm
4) Subjects of either sex having Generalised Chronic Periodontitis
5) Subjects who are systemically healthy with no contraindication to Periodontal surgery.
6) Presence of PD ≥ 5mm with radiographic evidence of angular bone loss.
7) Compliant subjects.
 
 
ExclusionCriteria 
Details  1) Subjects having any deleterious habits, such as smoking or tobacco chewing.
2) Subjects with history of any systemic disease.
3) Subjects who are sensitive to or shows any allergic reaction to any medication or any ingredient of the test- material.
4) Periodontal defect sites with one walled intra-bony defect.
5) Subjects showing unacceptable oral hygiene compliance during / after Phase-I therapy.
6) Pregnant or lactating females.
7) Subjects having undergone any periodontal therapy in the past three months.
8) Subjects prescribed with steroids/chemotherapy/radiotherapy.
9) Patient with any bleeding disorders.
10) Patient taking any medication which may affect wound healing.
11) Non-compliant subjects.

 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Clinical attachment level/ Relative attachment level, Radiographic bone fill  3 Months and 6 Months 
 
Secondary Outcome  
Outcome  TimePoints 
Probing pocket depth  3 Months and 6 Months 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "20"
Final Enrollment numbers achieved (India)="20" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/12/2024 
Date of Study Completion (India) 13/05/2026 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Yet Recruiting 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
IN PROCESS OF PUBLICATION 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
Patients with intrabony defects confirmed with a radiograph, will be subjected to open flap debridement + DFDBA with or without rhBMP-2. Patient will be inducted for study and after obtaining written consent. Phase 1 therapy will be carried out. This will be followed by the surgical procedure in the patients as mentioned above. Patient will be recalled after 1 week for re-evaluation and assessment followed by 3 months and 6 months. 
Close